The SIRveNIB and SARAH trials and the role of SIR-Spheres® Y-90 resin microspheres in the management of hepatocellular carcinoma

Future Oncology, Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2ge3bDj
via IFTTT